We are building on a rich legacy in oncology with a rejuvenated pipeline and a renewed commitment to bring novel treatment options to patients with unmet medical needs. Today, Sanofi Genzyme has a portfolio of medicines indicated across a variety of cancers, including skin, prostate, lung, colon, and breast.